Connect your AI

Eli Lilly LLY Accounts Receivable

Accounts Receivable at other companies

PfizerPFE

$12.59B+6.2%

AmgenAMGN

$9.14B+12.4%

Cardinal HealthCAH

$13.65B+7.8%

MannkindMNKD

$28.14M-2.6%

McKessonMCK

$27.99B+9.1%

ExelixisEXEL

$328.95M+16.8%

Other financials

Income statement

Revenue$19.8B+55.5%

Gross profit$16.2B+54.4%

Net income$7.4B+168%

EPS (diluted)$8.26+170%

Balance sheet

Cash & equivalents$5.3B+70.8%

Total debt$43.4B+12.6%

Total equity$31.2B+97.9%

Total assets$116.58B+30.4%

Cash flow

Operating cash flow$5.3B+220%

CapEx$2.3B+54.0%

Free cash flow$3.0B+1,828%

Valuation

Market cap$1.09T+56.4%

Enterprise value$1.12T+53.8%

P/E42.9×-7.3×

P/S15×+2.0×

Profitability

Gross margin82.8%+1.1pp

Net margin35%+12.3pp

FCF margin16.4%+8.7pp

Returns & leverage

Return on equity107.6%+29.9pp

Debt / equity1.4×-1.1×

Current ratio1.5×+0.1×

Where this comes from

Reported directly by Eli Lilly in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.

The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eli Lilly's accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Eli Lilly's accounts receivable?: Eli Lilly (LLY) reported accounts receivable of $18.43B in Q1 2026.
How has Eli Lilly's accounts receivable changed year-over-year?: Eli Lilly's accounts receivable increased by 53.1% year-over-year, from $12.04B to $18.43B.
What is the long-term trend for Eli Lilly's accounts receivable?: Over 5 years (2020 to 2025), Eli Lilly's accounts receivable has grown at a 24.8% compound annual growth rate (CAGR), from $5.88B to $17.76B.
What does accounts receivable mean?: Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.